(U.S. Food and Drug Administration/Public domain)

Six-month implant newest option to treat addiction amid opioid crisis

B.C. has been the hardest hit by opioid-linked deaths in the past two years

Canadians addicted to opioids may be eligible for an implant that provides an ongoing low dose of medication for six months, with the potential for treatment for up to a year when a new implant is placed in the opposite arm.

The procedure involves trained physicians inserting match-stick sized rods under the skin of the upper arm, each containing the medication buprenorphine.

Health Canada approved the implant in April 2018, two years after it was granted approval in the United States. It is marketed under the brand name Probuphine and is the first such implant for the treatment of addiction to opioids.

Dr. Seonaid Nolan, a clinical researcher with the BC Centre on Substance Use and an addiction medicine physician at St. Paul’s Hospital in Vancouver, said the implant is another treatment option alongside medications including Suboxone, the recommended treatment for an opioid addiction, followed by methadone.

“It’s so important to have a number of treatment options because there’s no one-size-fits-all for turning the tide on the opioid crisis,” said Nolan, who is also medical director of the addiction program at Providence Health Care.

The implant’s main advantage is that it eliminates barriers such as patients having to remember to take daily tablets of Suboxone, which can be a particular challenge for those entrenched in addiction while battling issues such as poverty, lack of housing and unemployment, she said.

The implant would also do away with the need for patients to take a drug under supervision, at least initially, in order to ensure compliance and deal with risks of it being diverted or misused.

Nolan said one addiction-medicine doctor at St. Paul’s Hospital has been trained on how to insert the implant, considered a viable option for people being released from correctional facilities, residential treatment programs and prolonged hospital stays because their tolerance to illicit opioids would be markedly reduced, putting them at higher risk of overdose.

The Canadian Agency for Drugs and Technologies in Health, which reviews all drugs and devices approved by Health Canada, said in a statement it has recommended provincial drug plans reimburse the cost of the implant for patients who have been stabilized on no more than eight mg of buprenorphine, in conjunction with counselling.

The agency’s drug-expert committee says the cost of the implant should not exceed the total drug plan cost of buprenorphine at a dose not exceeding eight milligrams a day.

The Health Ministry in British Columbia, the hardest-hit province in the overdose crisis, with more than 3,000 fatalities over the past two years, said the province’s independent Drug Benefit Council is conducting its own review of the implant before it determines whether the cost will be covered.

Montreal-based Knight Therapeutics licensed the implant from a U.S. company to commercialize and distribute it in Canada.

Knight Therapeutics president Samira Sakhia said the cost would be $1,495 per implant, equivalent to six months of treatment on Suboxone.

The company has trained doctors in major Canadian cities on how to insert the implant, she said.

“We are early in our launch. What we’re trying to do is make sure that if a physician has a patient who they feel would benefit from Probuphine what we would do is co-ordinate with that physician so that if they’re not trained they have access to someone who is trained and is close enough to them and their patient.”

READ MORE: B.C. opioid overdoses still killing four people a day, health officials say

READ MORE: Health Canada warns against giving opioid-containing cough, cold meds to youth

Sakhia said one patient, in the Maritimes, has so far received the implant in Canada.

“It’s a complicated product because of the nature of it being an implant and we are trying to do what we can to make sure that physicians are trained, knowledgeable, and we’re working towards reimbursement because that will make access easier.”

Camille Bains, The Canadian Press


Like us on Facebook and follow us on Twitter.

Just Posted

Governor General’s Award-winning author launches her new book

Wendy Phillips’s ‘Baggage’ is told in experimental ‘free verse’ style

Pirates climb to first place in premier league

Mid Island baseball team wins four more to extend win streak to eight games

Nanaimo city councillors to hold e-town hall meeting on strategic priorities

Meeting will take place May 23 at the Vancouver Island Conference Centre

Editorial: Homelessness task force has to be more than misdirection

Task force won’t be able to address all the challenging issues that come before Nanaimo council

Nanaimo Heritage Festival helps highlight the long weekend

Parade and family activities took place downtown today, May 19

Nanaimo youth theatre group presenting ‘Hairspray Jr.’

Headliners director and actors agree musical’s message continues to resonate

Nanaimo ferry stops to let bear swim past

Queen of Oak Bay brakes for wildlife

Take-home drug testing kits latest pilot to help curb B.C.’s overdose crisis

Researchers look to see if fentanyl testing could be a useful tool for those who use drugs alone

Two cats die in house fire in Nanaimo

Fire happened just after 2 p.m. Sunday on Fifth Street, one resident displaced

Nanaimo author details hotel history along the E&N railway

Along the E&N tells the story of 32 establishments from Esquimalt to Campbell River

RDN looking into providing bus service 365 days a year

RDN transit committee to consider adding bus service on Christmas, New Year’s and Good Friday

Wheelchair basketball in Nanaimo accessible to all abilities

Harbour City Slam play day introduced newcomers to the sport

Speed limit lowered at Departure Bay Beach

Speed limit reduced to 40 km/h until the fall

B.C. VIEWS: Reality of our plastic recycling routine exposed

Turns out dear old China wasn’t doing such a great job

Most Read